Renal Denervation (Symplicity Spyral™)

DEVICE3 trials

Sponsors

Medtronic Vascular

Conditions

Cardiovascular DiseasesChronic Kidney DiseasesDiabetes MellitusHypertensionVascular Diseases

Unknown Phase

SPYRAL DYSTAL Renal Denervation Global Clinical Study

CompletedNCT04311086

Medtronic VascularCardiovascular Diseases, Hypertension, Vascular Diseases

Start: 2020-06-12End: 2022-12-22Updated: 2024-04-17

SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN

Active, not recruitingNCT05198674

Medtronic VascularCardiovascular Diseases, Chronic Kidney Diseases, Diabetes Mellitus +2

Start: 2021-10-20End: 2029-11-30Updated: 2026-09-14

Longitudinal Real-world Clinical Outcomes Study on Symplicity Renal Denervation

RecruitingNCT07174622

Medtronic VascularCardiovascular Diseases, Hypertension, Vascular Diseases

Start: 2025-10-28End: 2029-06-01Target: 1000Updated: 2026-04-22